about
Rare lung diseases III: pulmonary Langerhans' cell histiocytosisMeasurement of T Cell Alloreactivity Using Imaging Flow CytometryOutcomes of a natural rubber latex control program in an Ontario teaching hospital.Autocrine IFNγ controls the regulatory function of lymphoproliferative double negative T cellsDouble negative regulatory T cells in transplantation and autoimmunity: recent progress and future directionsSyk Regulates Neutrophilic Airway Hyper-Responsiveness in a Chronic Mouse Model of Allergic Airways Inflammation.Molecular pathogenesis of lymphangioleiomyomatosis: lessons learned from orphansRare lung diseases I--Lymphangioleiomyomatosis.Quantification of CD4(+) T Cell Alloreactivity and Its Control by Regulatory T Cells Using Time-Lapse Microscopy and Immune Synapse Detection.Rare lung disease II: pulmonary alveolar proteinosis.Circulating Cell Death Biomarkers May Predict Survival in Human Lung Transplantation.Safety and Efficacy of Ex Vivo Donor Lung Adenoviral IL-10 Gene Therapy in a Large Animal Lung Transplant Survival Model.Desquamative interstitial pneumonitis in a patient with systemic lupus erythematosus.Pretreatment proliferation parameters do not add predictive power to clinical factors in cervical cancer treated with definitive radiation therapy.High dose intravenous methylprednisolone in the treatment of severe acute respiratory syndrome.Regulatory CD4(-)CD8(-) double negative T cells.Prostaglandin E2 signaling through E prostanoid receptor 2 impairs proliferative response of double negative regulatory T cells.Regulation of antigen-expressing dendritic cells by double negative regulatory T cells.Successful Lung Transplantation From Hepatitis C Positive Donor to Seronegative Recipient.Timing of nocturnal ventricular ectopy in heart failure patients with sleep apnea.Pentraxin 3 deficiency enhances features of chronic rejection in a mouse orthotopic lung transplantation model.Halofuginone treatment reduces interleukin-17A and ameliorates features of chronic lung allograft dysfunction in a mouse orthotopic lung transplant model.Higher M30 and high mobility group box 1 protein levels in ex vivo lung perfusate are associated with primary graft dysfunction after human lung transplantation.FcRγ promotes T cell apoptosis in Fas-deficient mice.Sequential broncho-alveolar lavages reflect distinct pulmonary compartments: clinical and research implications in lung transplantation.Innate Control of Tissue-Reparative Human Regulatory T CellsA novel combined ex vivo and in vivo lentiviral interleukin-10 gene delivery strategy at the time of transplantation decreases chronic lung allograft rejection in miceRejection of tracheal allograft by intrapulmonary lymphoid neogenesis in the absence of secondary lymphoid organsEpithelial cell death markers in bronchoalveolar lavage correlate with chronic lung allograft dysfunction subtypes and survival in lung transplant recipients-a single-center retrospective cohort studyBronchiolitis obliterans syndrome as manifestation of lung GVHD: Not the only oneNeutrophil extracellular traps in ex vivo lung perfusion perfusate predict the clinical outcome of lung transplant recipientsLentiviral interleukin-10 gene therapy: Safety and questionsCytokine profile in lung transplant recipients with Aspergillus spp colonizationMolecular assessment of rejection and injury in lung transplant biopsiesA B cell-dependent pathway drives chronic lung allograft rejection after ischemia-reperfusion injury in miceDonor human leukocyte antigen-G single nucleotide polymorphisms are associated with post-lung transplant mortality
P50
Q24616755-C427956B-72CB-4ECA-80F2-C332CA31DE2DQ33614049-46C61201-A9F1-42FD-ACA3-F05FBA42731DQ34394624-4B9EDD6D-C7AE-44FA-AF01-7C137F297E5CQ34451062-F96EC37E-E68D-4E29-A028-253566D69466Q35716736-7A459864-7E64-4ADF-A16D-F61D0C088ED2Q36255291-2D5E8BD3-720E-4B42-9914-08C29FF646E5Q36330644-0F78D4AF-6C4E-4B04-AF02-AEE657E50F45Q36621457-8BA9AB7C-1608-4C6B-BDB1-3F6CEB13351CQ36866534-89327910-2156-47FF-9E9C-FAA26F020CFAQ37181748-C9502426-3858-4E0B-BCAD-E4217E063270Q40077102-4A60752B-79E2-4603-BF34-E0D467645AE3Q40396319-931D246D-3086-4617-B0F4-5E20AF229ED2Q41816049-E7D706CA-521D-4E9F-BC03-3EAE0030D383Q44615040-A8BDDCFC-8FC3-40F7-B464-D577DD619896Q44978921-8F7CC86E-A5E3-41B5-9C4A-D24A66153415Q45902034-ED66FB79-176B-418B-91AE-AE9F70481840Q45962432-03EA91C4-811C-4674-A1AC-BE900A4241D9Q46176471-0870BCD0-C5EF-4175-97C9-A726B7729512Q47984154-ABA0CEE7-7450-4049-AAD4-9EE00C808970Q48444034-F411D4EE-FD8A-4D25-8C9B-4F36A6E24DE3Q50355668-1AD4E253-3E7D-4210-A57E-8AB90269C139Q50539568-646ABBF9-94DB-4BFD-A584-26399397E0F7Q50540199-CC01BF98-561A-43EA-9F79-2AFA97309D81Q53125022-3FA2105B-385F-4719-9028-9BA0D645E923Q55012331-4273DD3C-48C6-44B9-9841-FCA798597D29Q62682510-B01A0B10-2EB8-4230-B5A6-6FC1CE07E6DBQ64376932-4D3F31A4-A5D4-437A-838C-D3A67D83EEFAQ85895871-413D3B3B-7F95-4987-9897-2DC5A46D61F1Q90012179-2A85404A-8D63-49A7-B470-46A243DFEB71Q90027478-0AEAC5C6-D7F0-4D27-ADAE-5299D6E08472Q91098391-89AC7087-BAAA-4D6B-A4F8-DE87AE410A86Q91162277-8C0D5AB6-FAEB-42B4-8922-3022A51BB998Q91502924-7A6B2CF7-CB03-423F-84AC-50DC3DBAA78BQ91656652-4C4ED2BA-158D-45D9-9C3B-E32337D532EAQ92314008-6439D855-A18D-4731-ADF8-5FBCAA06A286Q92524179-0387DFB2-5BE9-4EC3-92EB-448FC2A0D9CB
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Stephen C Juvet
@ast
Stephen C Juvet
@en
Stephen C Juvet
@es
Stephen C Juvet
@nl
Stephen C Juvet
@sl
type
label
Stephen C Juvet
@ast
Stephen C Juvet
@en
Stephen C Juvet
@es
Stephen C Juvet
@nl
Stephen C Juvet
@sl
altLabel
Stephen C. Juvet
@en
prefLabel
Stephen C Juvet
@ast
Stephen C Juvet
@en
Stephen C Juvet
@es
Stephen C Juvet
@nl
Stephen C Juvet
@sl
P106
P21
P31
P3835
stephen-juvet
P496
0000-0002-7243-556X